SOSV is a global venture capital firm founded in 1995 and headquartered in New Jersey. The firm focuses on seed-to-growth investments in deep tech sectors, including biotech and life sciences, hardware and robotics, and cross-border software with emphasis on markets in Asia. It supports startups from early stages with investment capital as well as resources such as laboratories, collaborative spaces, and expert mentorship to accelerate product development and market traction. SOSV operates purpose-built programs to help portfolio companies raise follow-on funding, scale operations, and reach customers, often through structured matchmaking and access to a global network of investors. With a broad portfolio spanning hundreds of companies worldwide, SOSV aims to foster innovation, build vibrant entrepreneurial ecosystems, and contribute to sustainable technological advancement.

Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.

Khosla Ventures is a California-based venture capital firm founded in 2004 and headquartered in Menlo Park. It provides capital and strategic guidance to technology companies across stages, investing in sectors including artificial intelligence, digital health, sustainability, climate tech, and consumer technology. The firm seeks startups with innovative technologies or business models and offers hands-on support to help build enduring companies. It manages multiple funds and runs initiatives such as Khosla Impact, which supports high-impact for-profit ventures addressing the needs of low-income populations and emerging markets. Through funding and guidance, it backs transformative technologies and scalable businesses in the United States and globally.

Qiming Venture Partners is a China-based venture capital firm founded in 2006, with offices in Shanghai, Beijing, Suzhou, Hong Kong and Singapore. It backs early and growth-stage technology, consumer and healthcare companies, applying deep industry knowledge and hands-on support to help portfolio companies scale. The firm manages US-dollar and RMB funds and maintains a global footprint, including a dedicated US arm, Qiming Venture Partners USA, to pursue cross-border opportunities in healthcare, therapeutics and digital health. Since inception, it has invested in more than 530 companies and achieved more than 200 exits via IPOs, M&A or other means, with over 70 portfolio companies reaching unicorn or super unicorn status. Qiming emphasizes long-term partnerships with entrepreneurs, aligning resources and networks to drive innovation and societal progress across its portfolio.

Alumni Ventures is a venture capital firm founded in 2014 and based in Manchester, New Hampshire. It connects accredited individual investors with startup deals and co-invests alongside established venture capital firms across multiple stages, from seed to growth. The firm provides access to diversified portfolios through funds, syndicates, and investing clubs, supported by a large network of community members and individual investors. It invests across sectors and geographies, with a focus on transparency and due diligence in collaborative investments with leading firms such as Andreessen Horowitz, Sequoia, and Y Combinator. Alumni Ventures operates internationally with offices in New York, Boston, Menlo Park, Chicago, London, and Tokyo and has raised substantial capital to back founders with strategic capital and resources.

General Catalyst is a venture capital firm that provides early-stage and growth equity investments in technology companies. Founded in 2000 and based in the United States, the firm backs startups across consumer, enterprise software, fintech, crypto, and health technologies, offering mentorship and strategic guidance to help ideas scale. It participates in seed and growth rounds, often taking minority or majority stakes, and supports portfolio companies with resources and networks across North America and Europe.

Samsung Electronics is a global technology company headquartered in South Korea that designs, manufactures, and sells a broad range of electronics and information technology products. The company operates in consumer electronics, mobile communications, IT, and device solutions, offering smartphones, tablets, TVs, home appliances, PCs, memory and storage products, and other electronic components. It is a leading producer of semiconductors and display technologies and supplies components for its own devices as well as external customers. Samsung Electronics maintains a worldwide presence across regions including Korea, North America, Europe, and the Asia-Pacific, supports repair and service for its products, and invests in research and development to advance advanced materials, processing, and new architectures. It is widely regarded as the largest smartphone and television manufacturer in the world, underpinning a broad ecosystem of devices and technologies.

Antler is a global venture capital firm founded in 2017 and based in Singapore that invests in technology companies and incubates startups across diverse sectors. It supports founders from day one with a worldwide community of co-founders, access to talent, expert advisors, and expansion support, complemented by capital to help launch and scale ventures. Through regional funds and programs, Antler backs early-stage ventures across geographies, facilitating collaboration among founders and providing resources to help teams recruit, validate ideas, and enter markets.

Founders Fund is a San Francisco-based venture capital firm that invests across seed to growth stages in science and technology companies addressing difficult problems. The firm backs ventures across sectors such as aerospace, artificial intelligence, advanced computing, energy, health, consumer Internet, software, and related technologies, seeking transformative impact. It maintains a founder-friendly approach that emphasizes strong support with minimal interference. Founders Fund has backed notable companies including SpaceX, Palantir, Facebook, and Airbnb, and pursues a global investment footprint across the United States and beyond.

Ben Franklin Technology Partners of Southeastern Pennsylvania is a nonprofit organization founded in 1982 that strengthens the Philadelphia region's technology ecosystem by providing capital, strategic guidance, and professional connections to technology startups and growth companies across Philadelphia, Bucks, Delaware, Chester, and Montgomery counties. It serves as a seed-stage capital provider and investor across information technology, health, and physical sciences, advancing technology commercialization through university–industry partnerships and regional initiatives. The organization aims to accelerate innovation, create jobs, and build a robust entrepreneurial community by offering funding, mentorship, and access to a broad network of resources.

StartUp Health is a global organization and community founded in 2011 that unites health startups, scaleups, funders, thought leaders, and policymakers to accelerate healthcare innovation. It operates a network and programs called Health Moonshot Communities, supports more than 330 companies across six continents and 26 countries, and provides members with access to a network, programs, media content, and events to advance digital health, biotech, and life sciences solutions. The organization aims to improve health outcomes by fostering collaboration, strategic growth, and the pursuit of ambitious health moonshots such as improving access to care, curing disease, ending cancer, and advancing women's and children's health.

Right Side Capital Management is a San Francisco-based venture capital firm that focuses on early-stage technology companies, emphasizing capital-efficient startups across the United States and Canada. The firm targets pre-product-market-fit ventures and typically funds rounds in the tens of thousands to low hundreds of thousands of dollars, with round sizes commonly ranging from 50K to 500K. It employs a data-driven, rapid decision process and makes a high volume of investments annually, aiming to provide a firm yes or no within roughly two weeks. The team comprises seasoned founders who bring hands-on experience, and the firm operates like an operating company, delivering post-investment support and broad diversification across a large portfolio. Its activity spans multiple states beyond traditional hubs, reflecting a broad geographic reach and an emphasis on backing entrepreneurs overlooked by mainstream venture capital.

SFC Capital is a United Kingdom-based venture capital firm, founded in 2012, that backs early-stage startups across sectors such as software, technology, e-commerce, consumer, enterprise, fintech, healthcare, and digital health. It provides capital and strategic support to seed and pre-seed companies and operates primarily in the UK, with activity centered in London and Northwich.

IP Group is a global science and technology investment company focused on identifying, backing, and growing early‑stage, science‑based businesses. It commercialises intellectual property originating from research‑intensive institutions, managing the process from IP discovery to business development or the formation of strategic partnerships. The firm concentrates on HealthTech, DeepTech, and CleanTech, backing university spin‑outs and other innovative ventures with the potential to disrupt markets and deliver strong financial returns while delivering social and environmental impact aligned with the UN Sustainable Development Goals. IP Group leverages expertise in investment case development, governance, results reporting, and regulatory affairs, and cultivates collaborations with leading research institutions to accelerate growth. As a catalyst for innovation, it provides capital, strategic guidance, and operational support to portfolio companies to translate scientific advances into scalable technologies that benefit society and the economy.

Morningside Group is a venture capital firm founded in 1986, originally established as a family office for the Chan family, and is based in the greater Boston area. The firm makes venture investments in companies with novel science and technology, pursuing a long-term, patient approach to company-building and emphasizing ethical practices. Its investment focus spans life sciences, digital health, artificial intelligence, materials science, and information technology. In addition to its investment activities, Morningside supports charitable initiatives in education, research, and healthcare, with partnerships including the Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.

High-Tech Gründerfonds is a Germany-based venture capital firm that provides seed and early-stage financing to technology-focused startups. Founded in 2005, it operates as a public-private partnership with government and corporate investors to support German and European tech companies across digital technology, industrial tech, life sciences, chemistry and related areas. The firm offers capital and expertise to help startups move from concept to market, typically engaging in initial rounds and follow-on funding to accelerate growth. Since inception it has backed hundreds of startups and supported follow-on rounds, helping to stimulate innovation and entrepreneurship in Germany.

OrbiMed is a global healthcare investment firm founded in 1989 and based in New York, with a worldwide presence that includes offices in several regions. It allocates capital across private equity, venture capital, and public equity to support healthcare companies at various stages, from startups to established firms. Its focus spans biopharmaceuticals, medical devices, diagnostics, life sciences tools, and digital health, as well as healthcare services. The firm pursues opportunities across major markets in North America, Europe, and Asia, often leveraging region-specific teams to invest in companies in Israel, China, India, South Korea, and other jurisdictions. OrbiMed emphasizes building world-class companies by providing strategic financing, industry expertise, and global resources to portfolio companies in pursuit of medical breakthroughs and sustainable growth.

Northpond Ventures is a science-driven venture capital firm specializing in growth capital, headquartered in Bethesda, Maryland, with offices in San Francisco, California, and Cambridge, Massachusetts. Founded in 2018, it focuses on life sciences and technology sectors, including diagnostics, digital health, health tech, therapeutics, and artificial intelligence and machine learning. The firm backs growth-stage companies advancing biomedical research and technology-enabled healthcare, aiming to translate scientific advances into commercial solutions.

Gaingels is a venture capital organization focused on supporting LGBTQ+ founders and leaders and their allies. It invests across stages and industries, building a global portfolio of 130+ companies and deploying around $70 million in capital. Beyond funding, Gaingels helps portfolio companies recruit diverse C-suite and board talent and fosters a global community of investors, operators, and entrepreneurs working toward inclusive leadership and positive social change through business.

Keiretsu Forum is a global investment community of accredited private equity investors, venture capitalists, and corporate/institutional investors. It operates as an international network with chapters in numerous regions, connecting members through private equity funding, deal flow, and related activities. Members review opportunities presented through restricted forums and may invest in selected companies. The organization supports collaboration by providing access to capital, resources, and mentoring through its events and partnerships.

European Investment Fund is the European Union’s financing arm for small and medium-sized enterprises and mid-caps, providing financial instruments to improve access to affordable financing throughout a business lifecycle. It leverages its capital base to attract private investment through guarantees and equity funding, fostering public-private partnerships and crowding in lenders and investors to support SMEs and startups across EU member states, candidate countries, and EFTA. The EIF focuses on innovation, growth, competitiveness, social impact, and sustainability, and supports financing for sectors such as information technology, life sciences, energy, and manufacturing, helping close funding gaps and contribute to Europe’s economic resilience and strategic autonomy.

Mayo Clinic is a non-profit medical organization based in Rochester, Minnesota, established in 1864. It provides medical care across a wide range of specialties, supports education in clinical medicine and the medical sciences, and conducts extensive medical research through programs nationwide. The organization operates as a physician-led group practice and maintains entities such as Mayo Clinic Ventures, which translates inventions into patient care and educational and research initiatives, and Mayo Clinic Platform, an accelerator and incubator focused on health technology and artificial intelligence startups.

Legend Capital is a Beijing-based venture capital firm and the investment arm of Legend Holdings, founded in 2001 to back high-growth technology and related companies in China and markets connected to China. The firm concentrates on early-stage IT, telecommunications, media, healthcare, consumer services, modern services, and sectors such as infrastructure, clean technology, and advanced manufacturing. It provides portfolio companies with strategic resources, market access support, and tailored services to help with business development, branding, and navigating the Chinese market, aiming to create value and maximize returns for investors.

RA Capital Management is a Boston-based investment management firm specializing in growth-oriented and early-stage support for healthcare, life sciences, and planetary health companies. The company deploys capital across private seed rounds, series financings, and public markets, with a focus on drugs, medical devices, diagnostics, and tools that advance patient care. It leverages a science-driven approach through its research platform TechAtlas and provides value-added services such as board representation, executive recruitment, and market intelligence to portfolio companies. The firm operates an incubator program called Raven to nurture biomedical innovation and maintains an Innovator Resources program to guide company development. RA Capital emphasizes evidence-based investing, long-term partnerships, and social responsibility, aiming to drive value creation from inception through commercialization.

Sand Hill Angels is a member-driven angel investor group based in Mountain View, California, with a 60-plus member network that supports early-stage technology startups. Founded around 2000, the group provides seed to Series A funding, mentorship, and meaningful connections to customers, partners, and venture capital firms to help startups scale. Typical investments range from $300,000 to $500,000 in rounds with pre-money valuations under $5 million, and it backs companies across sectors such as semiconductors, enterprise software, storage, and communications, as well as clean technology, internet, information sciences, and life sciences including medical devices, diagnostics, and bioinformatics. Sand Hill Angels collaborates with other venture funds and angel organizations to foster the Bay Area ecosystem and broader North American tech growth, sourcing deals and building long-term partnerships.

Eli Lilly and Company is a global biopharmaceutical company engaged in discovering, developing, manufacturing, and marketing medicines across neuroscience, cardiometabolic, cancer, and immunology. The company operates manufacturing and distribution facilities in the United States, Puerto Rico, and multiple countries, with products sold in about 135 markets worldwide. Through ongoing research and development, Lilly aims to deliver therapies that improve patient outcomes and access to medicines. Its portfolio includes treatments such as Mounjaro and Jardiance for cardiometabolic diseases, Verzenio and Jaypirca for cancer, Trulicity and Humalog for diabetes, and Taltz and Olumiant for immunology, among others. Lilly emphasizes safety and quality in manufacturing and supports patients through educational and support initiatives, reflecting a long history of pharmaceutical leadership and a commitment to advancing personalized medicine.

Polaris Partners is a venture capital firm based in Boston, Massachusetts, founded in 1996. It invests in technology and life sciences companies across the United States and Europe, supporting multiple stages from early development to growth. Its portfolio spans software, healthcare information technology, digital health, biotechnology, pharmaceuticals, and related life sciences, with emphasis on molecules, platforms, therapeutics, genomics, and data-driven healthcare solutions. The firm maintains a presence in Boston and San Francisco and emphasizes deep engagement with founders, offering strategic guidance and network resources to accelerate growth.

Kurma Partners is a Paris-based investment firm focused on financing innovation in healthcare and biotechnology across development stages, from early discovery to later-stage growth. It backs therapeutics, diagnostics, health technology, and digital health ventures in Europe, leveraging ties with research centers and hospitals to translate scientific advances into clinical and commercial success. The firm operates with a Europe-wide reach, with a notable presence in France, and emphasizes collaborating with researchers and entrepreneurs to support impactful, sustainable healthcare solutions.

Deerfield Management is a New York-based healthcare investment firm focused on long-term, structured investments in public and private healthcare companies. Founded in 1994, it manages a diversified portfolio spanning therapeutics, medical devices, diagnostics, digital health, and health services. The company combines investment activity with information services and philanthropy, leveraging Deerfield Intelligence, an approach that uses AI, data, and market research to inform decisions. It supports innovation through initiatives such as Deerfield Discovery and Development and the Deerfield Foundation, which aims to improve children's health worldwide. Through its capital and strategic insight, Deerfield seeks to connect capital, ideas, and technology to advance human health.

Innovation Works is a Pittsburgh-based nonprofit economic development organization founded in 1988 to foster growth of early-stage technology startups in Southwestern Pennsylvania. It provides funding, mentorship, and programs across software, robotics, hardware, and life sciences, and supports manufacturers in adopting new technologies. As an affiliate of Ben Franklin Technology Partners, it combines resources with regional partners to build an innovation ecosystem, offering accelerator programs such as AlphaLab Robotics Factory and connections to investors and industry experts. Through its programs, Innovation Works aims to create jobs and drive regional prosperity by helping startups scale from seed stage to follow-on funding.

Matrix Partners is a venture capital firm founded in 1977 and based in San Francisco that funds early-stage technology companies. The firm focuses on applied AI, B2B software, fintech, health tech, infrastructure and hardware, and supports ventures from idea to Series A with a hands-on, founder-friendly approach drawn from its team of former entrepreneurs. It has backed and partnered with companies such as Apple, FedEx, Oculus, Canva, Zendesk and HubSpot, Postmates and Fivetran, illustrating a history of broad technology investments across the United States, China and India. Matrix Partners combines local knowledge with global experience to help portfolio companies scale into category-leading businesses.

Parkwalk Advisors is a London-based venture capital firm focused on investing in UK university spinouts and other research-intensive technology companies across sectors such as artificial intelligence, big data, life sciences, cleantech, materials, medical technology, quantum computing and the future of mobility. The firm targets early- to growth-stage opportunities and typically engages in seed to growth capital rounds, prioritizing UK-based companies originating from university research. Parkwalk leverages academic networks, technology transfer offices and venture ecosystems to access high-quality deal-flow and supports portfolio companies through development toward scale. Founded in 2009, Parkwalk operates in connection with IP Group, a university IP commercialisation company.

eHealth Ventures is a Tel Aviv, Israel-based venture capital firm that backs early-stage digital health companies, focusing on digital health, digital diagnostics, and therapeutics. It supports portfolio companies through strategic partnerships, access to EMR datasets, and connections with industry leaders to advance clinical integration, validate business models, and enable commercial expansion. The firm leverages government non-dilutive funding and collaboration opportunities to accelerate growth and help portfolio companies scale to global markets.

BioVenture, established in September 2013, specializes in early-stage venture capital investments in the field of life sciences, focusing on biotechnology, drug discovery, medical devices, and healthcare services companies. With a fund size of 540 million yuan, BioVenture provides capital and post-investment support to innovative companies with high growth potential. Backed by Suzhou Industrial Park and BioBay, BioVenture aims to become one of China's most successful medical and pharmaceutical venture funds by leveraging its industry expertise and resources. The team at BioVenture consists of senior investment professionals with deep knowledge of domestic and foreign markets, aiming to help companies grow rapidly and achieve greater success while delivering considerable returns to fund investors. Through joint venture development cooperation, BioVenture seeks to drive innovation and growth in the medical and pharmaceutical industry.

IMM Investment is a Seoul-based independent private equity and venture capital firm established in 1999. The company engages in mezzanine and growth investments and pursues opportunities in mergers and acquisitions, venture capital, corporate restructuring, private equity, industry consolidation, management buyouts, spin-offs, recapitalizations, and cross-border transactions. It concentrates on medium-sized companies operating in information technology infrastructure, wireless communications, software, contents, and other technology-enabled sectors, with a particular emphasis on information technology, healthcare/biotech, and manufacturing. The firm typically takes an active role in governance and strategic direction and focuses on opportunities within South Korea and cross-border contexts. IMM Investment aims to support portfolio companies through growth, expansion, and consolidation, leveraging its long-standing relationships with institutional investors and investment professionals.

aMoon Fund is a healthtech and life sciences venture capital firm based in Ra'anana, Israel, founded in 2017 by Marius Nacht and Dr. Yair Schindel. It backs early- to growth-stage companies across the United States, Europe, and Israel that develop biopharma, digital health, medical technology, and related life sciences solutions. The firm partners with management teams to leverage advanced science and technology to accelerate cures for life-threatening conditions and address global healthcare cost drivers, aiming to create meaningful patient impact and scalable value in the health economy.

WI Harper Group is a cross-border venture capital firm with offices in Beijing, Taipei, and San Francisco. Founded in 1993, it focuses on early and early expansion investments across the United States, Greater China, and the Asia Pacific, with a history of backing technology, healthcare, clean technology, and related sectors. The firm pursues a global-local approach, providing financing, strategic guidance, and partnerships to help startups through early growth toward exits such as IPOs or acquisitions.

Felicis Ventures is a Menlo Park-based venture capital firm founded in 2006 that backs early-stage technology startups globally. The firm emphasizes founder-first investing and provides more than capital through mentorship and strategic guidance, aiming to help portfolio companies scale from seed through growth stages. Its focus spans software, information technology, and TMT, with activity across sectors including artificial intelligence, cybersecurity, health, energy, and education. Felicis has backed a number of notable companies, such as Shopify, Canva, and Notion, and maintains a diverse portfolio across multiple countries, reflecting a global investment approach.

Casdin Capital is an investment firm focused on life sciences and healthcare. Founded in 2012 by Eli Casdin and based in New York, it seeks opportunities across the life sciences spectrum, including biotechnology, digital health, oncology, agtech, and healthcare services. The firm pursues early- to late-stage private investments and, at times, long-short equity strategies, leveraging data-driven insights, molecular information, and precision medicine to identify transformative opportunities. It emphasizes patient capital, disciplined investing, and strong collaborations to support companies advancing diagnostics, therapeutics, and sustainable solutions. By capturing and processing data to unlock breakthroughs, Casdin Capital backs teams with the potential to transform modern medicine.

Alexandria Venture Investments is the strategic venture capital arm of Alexandria Real Estate Equities. It provides seed through growth capital to life science and technology companies developing breakthrough therapies, diagnostics, research tools, agrifoodtech, agtech, digital health, and related platforms. Backed by the parent company’s industry experience and scientific advisory network, the firm leverages long-standing relationships and domain expertise to support early to growth-stage ventures aiming to translate scientific advances into practical healthcare and technology solutions.

Par Equity is a venture capital and private equity firm backed by Scottish Enterprise, based in Edinburgh with an office in San Francisco. It specializes in early‑stage and growth investments in technology companies, including software, deep tech and digital health, targeting opportunities in Scotland, Northern England and Northern Ireland, with cross‑border expansion between the United Kingdom and the United States. The firm funds proprietary technology and proven products poised for international growth, supporting UK companies expanding to the United States and US entrants seeking a UK presence. Typical investments range from £0.25 million to £2.5 million, with enterprise values up to about £10 million. It also provides angel capital to investee companies and focuses on cross‑border deals to accelerate scale.

HealthTech Capital is a membership-based angel investor network and mentoring program founded in 2010 and based in Los Altos Hills, California. It connects accredited angel investors with early-stage health technology and medical technology startups, healthcare systems, venture and corporate partners, and clinical providers to foster deal flow and collaboration. The organization supports portfolio companies through mentoring, networking initiatives, and access to its broad network across the United States and Asia, with activities that combine funding and guidance to accelerate the development of innovative healthcare technologies at the intersection of healthcare, technology and mobility.

Accel is a venture capital firm founded in 1983 and headquartered in Palo Alto, California. It is an early and growth-stage investor that backs entrepreneurs building world-class technology companies across software, consumer, enterprise IT, information technology, healthcare, fintech, security, and media sectors. The firm emphasizes a global community of founders, operators, and resources, providing more than capital to help portfolio companies scale. Its investments span geographies including the United States, Europe, Israel, India, and other regions, and its portfolio has included notable companies such as Atlassian, Dropbox, Slack, Spotify, and many others. With decades of experience, Accel partners with teams to turn early-stage ideas into category-defining businesses and to accelerate growth through strategic guidance and networks. The firm focuses on practical, long-term support for scalable technology ventures.

New Enterprise Associates is a venture capital firm founded in 1977 and based in Menlo Park, California, with a global investment reach. It provides capital and operational support to early, growth, and later-stage companies across a wide range of industries, including software, consumer technology, healthcare technology, life sciences, energy technology, infrastructure, and AI-enabled services. NEA collaborates with founders to address technical challenges, guide product development, and expand markets, leveraging its domain expertise to help portfolio companies scale from seed stages through IPO. The firm invests across the United States, Asia, and other regions, often supporting companies from early stages to scale, and has a long track record that includes numerous IPOs and acquisitions. NEA emphasizes a hands-on partnership approach and seeks opportunities across sectors that enable transformational businesses through technology and data-driven innovation.

Entrepreneur First is a London-based accelerator and early-stage technology investor that identifies exceptional technical founders and helps them launch startups. Founded in 2011, EF operates globally with offices in London, Paris, Bangalore, New York and San Francisco, connecting talent to Silicon Valley and other startup ecosystems. It runs six-month accelerator programs and seed funding across markets, supporting pre-team and pre-idea participants and often providing stipends or early investments in exchange for equity. EF focuses on proprietary technology and aims to move capable founders toward independent, scalable ventures across industries. Its portfolio is valued at over 13 billion dollars and includes unicorns and notable exits, reflecting a broad network of investors. By coordinating a global network, EF helps founders relocate and scale internationally.

ARCH Venture Partners is a Chicago-based venture capital firm founded in 1986 that concentrates on science-driven startups, especially in life sciences, biotechnology, healthcare, and related technologies. It backs companies co-founded by scientists and entrepreneurs and supports commercialization of innovations developed at academic research institutions and national laboratories. The firm takes a long-term, hands-on approach, leveraging its network to assist portfolio companies from inception to market realization and to build transformative enterprises. ARCH has raised ten venture funds totaling over $3 billion and has invested in more than 150 companies worldwide, reflecting a focus on strategic value creation and governance.

Jumpstart Foundry is a Nashville-based venture capital firm and accelerator that funds and supports early-stage healthcare companies. It focuses on healthcare information technology, consumer health products and services, tech-enabled services, and diagnostic devices, generally excluding biotech, pharmaceuticals, and life sciences companies. The firm combines investment with hands-on guidance by connecting portfolio companies to industry stakeholders and advising on marketing, growth, and talent. Founded in 2010, it operates a structured program consisting of a 14-week main accelerator and a six-week micro-accelerator, serving startups in the Nashville region with a broader U.S. footprint and an additional office in Atlanta. Jumpstart Foundry is part of a broader Jumpstart ecosystem that emphasizes mentorship, resources, and collaboration to accelerate healthcare innovation.

Novo Nordisk is a global healthcare company focused on discovering, developing, and delivering medicines for chronic diseases, with insulin and diabetes care at its core. It develops and distributes insulin and other diabetes therapies, and invests heavily in scientific research and biotechnology to advance breakthroughs. The company operates worldwide, aiming to expand access to its treatments and improve patient outcomes, while emphasizing sustainability, partnerships, and social responsibility.

Sequoia Capital is a venture capital firm founded in 1972 and based in Menlo Park, California. It provides capital alongside strategic guidance to a select set of companies across information technology, healthcare, manufacturing, mobile, nanotechnology, financial services, internet, energy, media, and retail, supporting them from early ideas through growth and even IPO stages. The firm emphasizes long-term partnerships, working closely with leadership teams on product development, company building, and market expansion. Sequoia pursues opportunities at seed, early, and growth stages and maintains a global reach, investing in companies across the United States and other major markets, with interests in AI and other emerging technologies.

Section 32 is a California-based venture capital firm founded by Bill Maris that backs early-stage technology, life science, and healthcare companies across the United States. The firm focuses on frontier technologies and seeks to accelerate discovery, development, and deployment of innovative solutions that improve the human condition. Its investment scope spans artificial intelligence, enterprise software, cybersecurity, fintech, quantum computing, computational biology, and biotechnology.